Recombinant Human MCP-1 protein (GST tag)
SKU: PDEH100193-100
To better serve you, we would like to discuss your specific requirement.
Please Contact Us for a quote.
Recombinant Human MCP-1 protein (GST tag)
SKU # | PDEH100193 |
Expression Host | E. coli |
Description
Synonyms | C-C motif chemokine 2;HC11;Monocyte chemoattractant protein 1;MCAF;Monocyte chemotactic protein 1;MCP-1;Monocyte secretory protein JE;CCL2 |
Species | Human |
Expression_host | E.coli |
Sequence | Gln 24-Thr 99 |
Accession | P13500 |
Mol_Mass | 33.3 kDa |
AP_Mol_Mass | 35 kDa |
Tag | N-GST |
Bio_Activity | Not validated for activity |
Properties
Purity | > 95 % as determined by reducing SDS-PAGE. |
Endotoxin level | Please contact us for more information. |
Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
Reconstitution | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis |
Background
The chemokine (C-C motif) ligand 2 (CCL2), also known as monocyte chemoattractant protein (MCP)-1 and small inducible cytokine A2 (SCYA2), is a small cytokine that belongs to the CC chemokine family responsible for monocyte attraction. Its cognate receptor, CCR2, play a critical role in regulating nociceptive processes during neuropathic pain. Both CCL2 and CCR2 are implicated in induction of autoimmunity. CCL2 recruits monocytes, memory T cells, and dendritic cells to the sites of inflammation produced by either tissue injury or infection. Recently research also showed that CCL2 might be useful as a biomarker of fibrosis as well as a target for therapeutic intervention.